General Information of Drug Inactive Ingredient (DIG) (ID: E00083)

DIG Name
Hexahydric alcohol
Synonyms
D-Sorbitol; sorbitol; D-Glucitol; 50-70-4; glucitol; L-Gulitol; (-)-Sorbitol; Glucarine; Diakarmon; Multitol; Sorbilande; Sorbostyl; D-(-)-Sorbitol; Esasorb; Karion; Neosorb; Nivitin; Siosan; Sorbite; Sorbol; Cholaxine; Sionit; Sionite; Sionon; Karion instant; Sorbitol F; Sorbex Rp; Sorbitol FP; D-Sorbol; Sionit K; Sorbex M; Sorbex R; Sorbex S; Sorbex X; Sorbitol syrup C; Hexahydric alcohol; Sorbicolan; Sorvilande; Gulitol; Neosorb P 60; D-Sorbite; Foodol D 70; Neosorb 20/60DC; Neosorb 70/02; Neosorb 70/70; Neosorb P 20/60; (2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol; Karion (carbohydrate); Sorbo; Probilagol; D-1,2,3,4,5,6-Hexanehexol; d-Sorbit; FEMA No. 3029; Sorbitol solutions; CCRIS 1898; Glucitol, D-; G-ol; AI3-19424; HSDB 801; iso-sorbide; (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; Glc-ol; 98201-93-5; MFCD00004708; NSC 25944; Sorbit; UNII-506T60A25R; CHEBI:17924; Resulax; Sorbilax; 506T60A25R; 1,2,3,4,5,6-Hexanehexol; D-Sorbitol, 97%; E420; Medevac; E 420; DSSTox_CID_3588; DSSTox_RID_77095; DSSTox_GSID_23588; Sorbitur; (2S,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol; Sorbit DP; CAS-50-70-4; SMR000112219; Sorbitol [USP:NF]; Sorbitol 3% in plastic container; WURCS=2.0/1,1,0/[h2122h]/1/; EINECS 200-061-5; Solbitol; SORBITOL 3.3% IN PLASTIC CONTAINER; NSC-25944; Sorbitol S; Sorbitol FK; Sorbit D-Powder; Sorbit S; Sorbit W-Powder; Sorbit WP; Sorbitol (NF); Neosorb P60; Sorbitol F solution; Kyowa Powder 50M; Sorbogem 712; Sorbitol (Glucitol); Neosorb P 60W; Sorbit D 70; Sorbit DP 50; Sorbit L 70; Sorbit T 70; Sorbit W 70; D-Sorbitol, 99%; Sorbit W-Powder 50; D-sorbitol; D-glucitol; D-Sorbitol (JP17); Sorbitol solution (USP); D-Sorbitol, >=98%; SCHEMBL763; Sorbit Kyowa Powder 50M; bmse000115; bmse000803; bmse001007; Epitope ID:114708; Isomalt impurity, sorbitol-; D-Sorbitol, NF/FCC grade; CHEMBL1682; MLS001333209; MLS001333210; D-Sorbitol, analytical standard; D-Sorbitol, for electrophoresis; DTXSID5023588; D-Sorbitol, BioXtra, >=98%; D-Sorbitol, for synthesis, 99%; HMS2094K21; HMS2270A18; Pharmakon1600-01300028; HY-B0400; Tox21_201937; Tox21_303388; ANW-73130; D-Sorbitol, >=98%, FCC, FG; NSC759608; s2393; ZINC18279893; AKOS015899604; D-Sorbitol, plant cell culture tested; 7B5697N; CCG-229392; D-Sorbit 1000 microg/mL in Methanol; DB01638; NSC-759608; Sorbitol 3% in plastic container (TN); D-Sorbitol solution, 70% in H2O, CP; NCGC00164353-01; NCGC00164353-02; NCGC00164353-03; NCGC00257447-01; NCGC00259486-01; AC-13186; CS-13177; D-Sorbitol, SAJ first grade, >=97.0%; SBI-0206688.P002; D-Sorbitol, for molecular biology, >=98%; D-Sorbitol, BioUltra, >=99.5% (HPLC); D-Sorbitol, SAJ special grade, >=99.0%; D-Sorbitol, Vetec(TM) reagent grade, 97%; E-420; S0065; SW220289-1; D-Sorbitol, crystallized, >=99.0% (HPLC); 9851-EP2277869A1; 9851-EP2280012A2; 9851-EP2281815A1; 9851-EP2298776A1; 9851-EP2311818A1; 9851-EP2316835A1; C00794; D00096; AB00919085_06; D-Sorbitol, liquid, tested according to Ph.Eur.; Q245280; mixed with ethyl acetate fraction of Plinia cauliflora; mixed with tannin enriched fraction of Plinia cauliflora; Sorbitol, European Pharmacopoeia (EP) Reference Standard; UNII-27F77DSJ5V component FBPFZTCFMRRESA-JGWLITMVSA-N; 75DE42C3-7C3B-4802-95E0-463F02268BDC; Sorbitol, United States Pharmacopeia (USP) Reference Standard; D-Sorbitol, BioReagent, cell culture tested, plant cell culture tested; Sorbitol, Pharmaceutical Secondary Standard; Certified Reference Material; Sorbitol F solution, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
DIG Function
Diluent; Flavoring agent; Humectant; Plasticizing agent
Formula
C6H14O6
Canonical SMILES
C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m1/s1
InChIKey
FBPFZTCFMRRESA-JGWLITMVSA-N
Physicochemical Properties Molecular Weight 182.17 Topological Polar Surface Area 121
XlogP -3.1 Complexity 105
Heavy Atom Count 12 Rotatable Bond Count 5
Hydrogen Bond Donor Count 6 Hydrogen Bond Acceptor Count 6

Full List of Drug(s) Co-administrated with This DIG

41 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetaminophen DMUIE76 Allergic rhinitis [CA08.0] Acetaminophen 160 mg tablet F00101
Alprazolam DMC7XDN Anxiety [] Alprazolam 0.25 mg tablet F00754
Amantadine DMS3YE9 Influenza A virus infection [1E30] Amantadine 100 mg capsule F00927
Aspirin DM672AH Acute coronary syndrome [BA41] Aspirin 325 mg tablet F01593
Benzonatate DM9U4FO Cough [MD12] Benzonatate 100 mg capsule F02353
Benzphetamine DMIJATC Obesity [5B81] Benzphetamine 50 mg tablet F02395
Bexarotene DMOBIKY Cutaneous T-cell lymphoma [2B01] Bexarotene 75 mg capsule F02507
Calcidiol DMN4CV5 Hypophosphatemia [] Calcifediol 0.03 mg capsule F03145
Calcitriol DM8ZVJ7 Congenital alopecia [LC30] Calcitriol 0.00025 mg capsule F03153
Carbamazepine DMZOLBI Epilepsy [8A60-8A68] Carbamazepine 200 mg tablet F03320
Cetirizine DMOMP9U Allergic rhinitis [CA08.0] Cetirizine 10 mg capsule F03877
Clonazepam DMTO13J Absence epilepsy [] Clonazepam 0.125 mg tablet F04590
Demeclocycline DMZEPFJ Acne vulgaris [ED80] Demeclocycline 150 mg tablet F05307
Dextromethorphan DMUDJZM Allergic rhinitis [CA08.0] Dextromethorphan 15 mg capsule F05298
Diclofenac DMPIHLS Chronic renal failure [GB61.Z] Diclofenac 25 mg capsule F05694
Didanosine DMI2QPE Human immunodeficiency virus infection [1C62] Didanosine 100 mg tablet F05853
Dimenhydrinate DM264B3 Meniere disease [AB31.0] Dimenhydrinate 50 mg tablet F06208
Diphenhydramine DMKQTBA Hyperemesis gravidarum [] Diphenhydramine 25 mg capsule F06292
Dutasteride DMQ4TJK Benign prostatic hyperplasia [GA90] Dutasteride 0.5 mg capsule F07174
Epanova DMHEAGL Hypertriglyceridemia [5C80.1] Omega-3 carboxylic acid 1000 mg capsule F15808
Ethambutol DMR87LC Pulmonary tuberculosis [1B10.Z] Ethambutol 100 mg tablet F07688
Ethosuximide DMDZ9LT Epilepsy [8A60-8A68] Ethosuximide 250 mg capsule F07706
Ibandronate DM0QZBN Hypercalcaemia [5B91.0] Ibandronic acid 150 mg tablet F10069
Ibuprofen DM8VCBE Dysmenorrhea [GA34.3] Ibuprofen 200 mg capsule F10109
Isotretinoin DM4QTBN Acne vulgaris [ED80] Isotretinoin 40 mg capsule F10891
Loratadine DMF3AN7 Allergy [4A80-4A85] Loratadine 10 mg capsule F12506
Lubiprostone DMJTEMW Chronic idiopathic constipation [DC32] Lubiprostone 0.024 mg capsule F12691
Naproxen DMZ5RGV Bursitis [] Naproxen 220 mg capsule F14980
Nifedipine DMSVOZT Angina pectoris [BA40] Nifedipine 20 mg capsule F15252
Nimodipine DMQ0RKZ Cerebral vasospasm [BA85.Z] Nimodipine 30 mg capsule F15378
Ondansetron DMOTQ1I Chemotherapy-induced nausea [MD90] Ondansetron 4 mg tablet F15955
Paricalcitol DMYBV3G Hyperparathyroidism [5A51] Paricalcitol 0.002 mg capsule F16591
Pseudoephedrine DMIVJ0D Allergic rhinitis [CA08.0] Pseudoephedrine 30 mg capsule F18243
Raltegravir DMYURI6 Human immunodeficiency virus infection [1C62] Raltegravir 100 mg tablet F18691
Risperidone DMN6DXL Bipolar I disorder [] Risperidone 3 mg tablet F19206
Rizatriptan DMDJMA3 Migraine [8A80] Rizatriptan 10 mg tablet F19345
Telmisartan DMS3GX2 Hypertension [BA00-BA04] Telmisartan 20 mg tablet F20715
Tofacitinib DMBS370 Rheumatoid arthritis [FA20] Tofacitinib 11 mg tablet F21188
Tretinoin DM49DUI Acne vulgaris [ED80] Tretinoin 10 mg capsule F21654
Vardenafil DMTBGW8 Cystic fibrosis [CA25] Vardenafil 10 mg tablet F22136
Zolpidem DMWOSKJ Insomnia [7A00-7A0Z] Zolpidem 1.75 mg tablet F22913
------------------
⏷ Show the Full List of 41 Approved Drug(s)